CoMI: consensus mutual information for tissue-specific gene signatures

Sing Han Huang, Yu Shu Lo, Yong Chun Luo, Yi Hsuan Chuang, Jung Yu Lee, Jinn Moon Yang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Background: The gene signatures have been considered as a promising early diagnosis and prognostic analysis to identify disease subtypes and to determine subsequent treatments. Tissue-specific gene signatures of a specific disease are an emergency requirement for precision medicine to improve the accuracy and reduce the side effects. Currently, many approaches have been proposed for identifying gene signatures for diagnosis and prognostic. However, they often lack of tissue-specific gene signatures. Results: Here, we propose a new method, consensus mutual information (CoMI) for analyzing omics data and discovering gene signatures. CoMI can identify differentially expressed genes in multiple cancer omics data for reflecting both cancer-related and tissue-specific signatures, such as Cell growth and death in multiple cancers, Xenobiotics biodegradation and metabolism in LIHC, and Nervous system in GBM. Our method identified 50-gene signatures effectively distinguishing the GBM patients into high- and low-risk groups (log-rank p = 0.006) for diagnosis and prognosis. Conclusions: Our results demonstrate that CoMI can identify significant and consistent gene signatures with tissue-specific properties and can predict clinical outcomes for interested diseases. We believe that CoMI is useful for analyzing omics data and discovering gene signatures of diseases.

Original languageEnglish
Article number624
JournalBMC Bioinformatics
StatePublished - May 2021


  • Omics data
  • Prognostic gene signature
  • Tissue-specific gene signature


Dive into the research topics of 'CoMI: consensus mutual information for tissue-specific gene signatures'. Together they form a unique fingerprint.

Cite this